KARYOPHARM THERAPEUTICS INC (KPTI) Stock Cash Flow
NASDAQ:KPTI - Nasdaq - US48576U2050 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.52M | -76.42M | -143.10M | -165.29M | -124.09M | |||
| Depreciation Amortization | 333.00K | 340.00K | 530.00K | 620.00K | 790.00K | |||
| Change In Working Capital | 8.89M | -302.00K | 31.41M | -19.99M | -23.19M | |||
| Interest Paid | N/A | 17.12M | 5.17M | N/A | N/A | |||
| Other non cash items | -69.44M | -51.10M | 18.43M | 35.11M | 39.37M | |||
| OPERATING CASH FLOW | -122.75M | -127.49M | -92.72M | -149.55M | -107.12M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 53.00K | -142.00K | 0.00 | -120.00K | -210.00K | |||
| Other Investing Activity | 88.77M | 95.61M | 7.94M | -104.14M | 142.05M | |||
| INVESTING CASH FLOW | 88.82M | 95.47M | 7.94M | -104.26M | 141.84M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 42.78M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 1.45M | 1.12M | 193.74M | 13.65M | |||
| Other Financing Activity | N/A | -2.59M | 0.00 | 0.00 | 60.00M | |||
| FINANCING CASH FLOW | N/A | 41.65M | 1.12M | 193.74M | 73.65M | |||
| Exchange Rate Effect | 10.00K | -11.00K | -34.00K | -490.00K | -50.00K | |||
| CHANGE IN CASH | 7.73M | 9.62M | -83.69M | -60.56M | 108.32M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -122.75M | -127.49M | -92.72M | -149.55M | -107.12M | |||
| Capital Expenditure | 53.00K | -142.00K | 0.00 | -120.00K | -210.00K | |||
| FREE CASH FLOW | -122.69M | -127.63M | -92.72M | -149.67M | -107.33M | |||
All data in USD